Warning! GuruFocus detected
1 Severe warning sign
with 6090.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Human Metabolome Technologies Inc
ISIN : JP3794530000
Description
Human Metabolome Technologies Inc is involved in the search and diagnosis of biomarkers and commercialization in the field of drug development.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.3 | |||||
| Equity-to-Asset | 0.79 | |||||
| Debt-to-Equity | 0.11 | |||||
| Debt-to-EBITDA | 0.83 | |||||
| Interest Coverage | 105.09 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 6.51 | |||||
| Beneish M-Score | -2.21 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.9 | |||||
| 3-Year EBITDA Growth Rate | 137 | |||||
| 3-Year FCF Growth Rate | 3.8 | |||||
| 3-Year Book Growth Rate | 13.3 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 76.45 | |||||
| 9-Day RSI | 67.6 | |||||
| 14-Day RSI | 65.77 | |||||
| 3-1 Month Momentum % | 16.47 | |||||
| 6-1 Month Momentum % | 14.22 | |||||
| 12-1 Month Momentum % | 11.34 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.84 | |||||
| Quick Ratio | 3.7 | |||||
| Cash Ratio | 3.19 | |||||
| Days Inventory | 33.14 | |||||
| Days Sales Outstanding | 77.46 | |||||
| Days Payable | 17.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.11 | |||||
| Dividend Payout Ratio | 0.39 | |||||
| Forward Dividend Yield % | 4.23 | |||||
| 5-Year Yield-on-Cost % | 2.11 | |||||
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | 2.16 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 64.6 | |||||
| Operating Margin % | 16.36 | |||||
| Net Margin % | 18.08 | |||||
| FCF Margin % | 12.49 | |||||
| ROE % | 12.85 | |||||
| ROA % | 9.98 | |||||
| ROIC % | 23.5 | |||||
| 3-Year ROIIC % | 52.42 | |||||
| ROC (Joel Greenblatt) % | 71.85 | |||||
| ROCE % | 13.77 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 17.26 | |||||
| PE Ratio without NRI | 18.49 | |||||
| Price-to-Owner-Earnings | 13.96 | |||||
| PS Ratio | 3.12 | |||||
| PB Ratio | 2.18 | |||||
| Price-to-Tangible-Book | 2.2 | |||||
| Price-to-Free-Cash-Flow | 24.95 | |||||
| Price-to-Operating-Cash-Flow | 14.71 | |||||
| EV-to-EBIT | 10.69 | |||||
| EV-to-EBITDA | 10.69 | |||||
| EV-to-Revenue | 2.1 | |||||
| EV-to-FCF | 16.31 | |||||
| Price-to-GF-Value | 0.94 | |||||
| Price-to-Projected-FCF | 3.63 | |||||
| Price-to-Median-PS-Value | 1.02 | |||||
| Price-to-Graham-Number | 1.21 | |||||
| Price-to-Net-Current-Asset-Value | 3 | |||||
| Price-to-Net-Cash | 3.91 | |||||
| Earnings Yield (Greenblatt) % | 9.35 | |||||
| FCF Yield % | 3.99 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Human Metabolome Technologies Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 1,345.671 | ||
| EPS (TTM) (円) | 41.104 | ||
| Beta | 0.03 | ||
| 3-Year Sharpe Ratio | 0.32 | ||
| 3-Year Sortino Ratio | 0.56 | ||
| Volatility % | 12.09 | ||
| 14-Day RSI | 65.77 | ||
| 14-Day ATR (円) | 12.336628 | ||
| 20-Day SMA (円) | 697.6 | ||
| 12-1 Month Momentum % | 11.34 | ||
| 52-Week Range (円) | 501 - 723 | ||
| Shares Outstanding (Mil) | 5.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Human Metabolome Technologies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Human Metabolome Technologies Inc Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Human Metabolome Technologies Inc Frequently Asked Questions
What is Human Metabolome Technologies Inc(TSE:6090)'s stock price today?
The current price of TSE:6090 is 円710.00. The 52 week high of TSE:6090 is 円723.00 and 52 week low is 円501.00.
When is next earnings date of Human Metabolome Technologies Inc(TSE:6090)?
The next earnings date of Human Metabolome Technologies Inc(TSE:6090) is .
Does Human Metabolome Technologies Inc(TSE:6090) pay dividends? If so, how much?
The Dividend Yield %  of Human Metabolome Technologies Inc(TSE:6090) is 2.11% (As of Today), Highest Dividend Payout Ratio of Human Metabolome Technologies Inc(TSE:6090) was 0.39. The lowest was 0.21. And the median was 0.21. The  Forward Dividend Yield % of Human Metabolome Technologies Inc(TSE:6090) is 4.23%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers